DORRIGOCINS - NOVEL ANTIFUNGAL ANTIBIOTICS THAT CHANGE THE MORPHOLOGY OF RAS-TRANSFORMED NIH/3T3 CELLS TO THAT OF NORMAL-CELLS .2. ISOLATION AND ELUCIDATION OF STRUCTURES
被引:27
作者:
HOCHLOWSKI, JE
论文数: 0引用数: 0
h-index: 0
机构:Pharmaceutical Products Research and Development, Abbott Laboratories, Illinois, 60064, Abbott Park
HOCHLOWSKI, JE
WHITTERN, DN
论文数: 0引用数: 0
h-index: 0
机构:Pharmaceutical Products Research and Development, Abbott Laboratories, Illinois, 60064, Abbott Park
WHITTERN, DN
HILL, P
论文数: 0引用数: 0
h-index: 0
机构:Pharmaceutical Products Research and Development, Abbott Laboratories, Illinois, 60064, Abbott Park
HILL, P
MCALPINE, JB
论文数: 0引用数: 0
h-index: 0
机构:Pharmaceutical Products Research and Development, Abbott Laboratories, Illinois, 60064, Abbott Park
MCALPINE, JB
机构:
[1] Pharmaceutical Products Research and Development, Abbott Laboratories, Illinois, 60064, Abbott Park
Two novel antifungal antibiotics, named dorrigocin A and B have been isolated from the fermentation broth and mycelium of Streptomyces platensis subsp. rosaceus. These closely related compounds were separated from one another by countercurrent chromatography on an Ito coil planet centrifuge. The structures of the dorrigocins were determined by NMR and IR spectroscopy and mass spectrometry. Each is a putative propionate-acetate derived straight chain fatty acid terminating in cycloheximide. The dorrigocins differ from one another only in their oxidation pattern.